ClassID:

95045

C07D311/20 - CPC Classification

Classification description:

Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems; Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 hydrogenated in the hetero ring

Recent Application in this class:
#1
20250320184
2025-10-16

SARM1 MODULATORS, PREPARATIONS, AND USES THEREOF

#2
20250313523
2025-10-09

FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES

#3
20250257046
2025-08-14

VITAMIN CATIONIC LIPIDS

#4
20240294465
2024-09-05

NOVEL ANTI-FIBROTIC DRUGS

#5
20230416209
2023-12-28

COMPOUNDS AND METHODS TO TARGET GLUCOSE-STIMULATED PHOSPHOHISTIDINE SIGNALING AND ESOPHAGEAL CANCER GROWTH

#6
20230348405
2023-11-02

PSMA-TARGETING COMPOUNDS AND USES THEREOF

#7
20230101009
2023-03-30

Therapeutics for the treatment of glaucoma

#8
20220259161
2022-08-18

PSMA-targeting compounds and uses thereof

#9
20220096426
2022-03-31

Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis

#10
20220048872
2022-02-17

PSMA targeted fluorescent agents for image guided surgery

#11
20210282443
2021-09-16

COMPOUNDS, COMPOSITIONS, AND METHODS FOR MODULATING SWEET TASTE

#12
20210206739
2021-07-08

Vitamin cationic lipids

#13
20210040148
2021-02-11

Therapeutics for the treatment of glaucoma

#14
20210030022
2021-02-04

NOVEL USE OF SUBSTITUTED CHROMAN-6-OLS

#15
20200299284
2020-09-24

Sulfonylureas and related compounds and use of same

#16
20200216402
2020-07-09

PSMA targeted fluorescent agents for image guided surgery

#17
20200109124
2020-04-09

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#18
20190314330
2019-10-17

IRE-1α inhibitors

#19
20190300495
2019-10-03

Nonionic surfactant

#20
20190262306
2019-08-29

Natural product derivatives for inhibiting cellular necroptosis, ferroptosis and oxytosis

#21
20190225593
2019-07-25

Substituted chromane-8-carboxamide compounds and analogues thereof, and methods using same

#22
20190100502
2019-04-04

2-(2,3-EPOXYPROPYL)PHENOL COMPOSITION AND METHOD OF MAKING

#23
20180312530
2018-11-01

PROCESSES FOR MAKING ALKYLATED ARYLPIPERAZINE AND ALKYLATED ARYLPIPERIDINE COMPOUNDS INCLUDING NOVEL INTERMEDIATES

#24
20180228765
2018-08-16

IRE-1α inhibitors

#25
20180222838
2018-08-09

Kynurenine-3-monooxygenase inhibitors, pharmaceutical compositions, and methods of use thereof

#26
20180099982
2018-04-12

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#27
20180022696
2018-01-25

N-acyl-arylsulfonamide derivatives as aminoacyl-tRNA synthetase inhibitors

#28
20180009767
2018-01-11

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#29
20180002306
2018-01-04

Compounds, compositions, and methods for modulating sweet taste

#30
20170326104
2017-11-16

IRE-1α inhibitors

#31
20170283384
2017-10-05

PSMA TARGETED FLUORESCENT AGENTS FOR IMAGE GUIDED SURGERY

#32
20170260152
2017-09-14

2-(2,3-epdxypropyl)phenol composition and method of making

#33
20170217920
2017-08-03

Antidiabetic bicyclic compounds

#34
20170056389
2017-03-02

5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from T. gondii and C. parvum

#35
20170002040
2017-01-05

Therapeutics for the treatment of glaucoma

#36
20170000178
2017-01-05

Compounds, compositions, and methods for reducing or eliminating bitter taste

#37
20160370700
2016-12-22

Photoresist composition, compound, and production method thereof

#38
20160221981
2016-08-04

Processes for preparing medicaments for the treatment of cardiovascular diseases and intermediates for use therein

#39
20160090362
2016-03-31

5-aminopyrazole-4-carboxamide inhibitors of CDPK1 from and

#40
20150361099
2015-12-17

Processes for making alkylated arylpiperazine and alkylated arylpiperidine compounds including novel intermediates

#41
20150237900
2015-08-27

Compounds, compositions, and methods for reducing or eliminating bitter taste

#42
20150210711
2015-07-30

Hexahydrodibenzo[a,g]quinolizine compound, preparation method thereof, pharmaceutical composition and use thereof

#43
20150184219
2015-07-02

Enzyme assays on a droplet actuator

#44
20150141424
2015-05-21

IRE-1α inhibitors

#45
20150104387
2015-04-16

PSMA-targeting compounds and uses thereof

#46
20140228434
2014-08-14

Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

#47
20140221423
2014-08-07

Agents and methods for treating ischemic and other diseases

#48
20140148400
2014-05-29

CARBONIC ANHYDRASE INHIBITORS WITH ANTIMETASTATIC ACTIVITY

#49
20140141460
2014-05-22

Assay for B-galactosidase activity

#50
20130281507
2013-10-24

Method for depigmenting keratin materials using resorcinol derivatives

#51
20130245268
2013-09-19

Enantioselective organic anhydride reactions

#52
20130224137
2013-08-29

SKIN LIGHTENING COMPOSITIONS

#53
20130203727
2013-08-08

Naphth-2-ylacetic acid derivatives to treat AIDS

#54
20130203688
2013-08-08

SUGAR PLANT DERIVED BY-PRODUCTS AND METHODS OF PRODUCTION THEREOF

#55
20130116247
2013-05-09

IRE-1α inhibitors

#56
20130102790
2013-04-25

Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives

#57
20130084252
2013-04-04

Use of certain neoflavonoids for intensifying and/or producing a sensory impression of sweetness

#58
20130079532
2013-03-28

Process for the preparation of 2-hydroxy-4-phenyl-3,4-dihydro-2H-chromen-6-yl-methanol and (R)-feso-deacyl

#59
20130029979
2013-01-31

Fused bicyclic compound

#60
20120329832
2012-12-27

Novel Insect-Repellent Coumarin Derivatives, Syntheses, and Methods of Use

#61
20120323016
2012-12-20

METHOD OF PREPARING DERIVATIVES/OLIGOMERS OF EPICATECHIN AND APPLICATIONS THEREOF

#62
20120136147
2012-05-31

Method of hydrolyzing an enzymatic substrate

#63
20120009121
2012-01-12

PSMA-targeting compounds and uses thereof

#64
20110318690
2011-12-29

COMPOUND, RESIN AND PHOTORESIST COMPOSITION

#65
20110294863
2011-12-01

Fungicide N-cycloalkyl-N-bicyclimethylene-carboxamide derivatives

#66
20110282094
2011-11-17

PROCESS FOR PREPARATION OF PHENOLIC MONOESTERS OF HYDROXYMETHYL PHENOLS

#67
20110245338
2011-10-06

Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

#68
20110196175
2011-08-11

Hydroxylation of β-dicarbonyls with zirconium catalysts

#69
20110193021
2011-08-11

Compound having hydrocoumarin skeleton, liquid crystal compostition, and liquid crystal display device

#70
20110112084
2011-05-12

Bicyclic androgen and progesterone receptor modulator compounds and methods

#71
20110105462
2011-05-05

MODULATORS OF DOPAMINE NEUROTRANSMISSION

#72
20110105461
2011-05-05

Modulators of dopamine neurotransmission

#73
20100298573
2010-11-25

Fluorescent agent having ethynyl group

#74
20100204218
2010-08-12

Fused bicyclic compound

#75
20100185014
2010-07-22

Hydroxylation of β-dicarbonyls with zirconium catalysts

#76
20100069652
2010-03-18

Process for preparing nebivolol

#77
20100069379
2010-03-18

Bicyclic androgen and progesterone receptor modulator compounds and methods

#78
20090306384
2009-12-10

Process for the production of benzopyran-2-ol derivatives

#79
20090267026
2009-10-29

Compound having hydrocoumarin skeleton, liquid crystal composition, and liquid crystal display device

#80
20090192224
2009-07-30

Chiral intermediate, process for producing the same and its use in the manufacture of tolterodine, fesoterodine, or the active metabolite thereof

#81
20080306259
2008-12-11

Hydroxylation of beta-dicarbonyls with zirconium catalysts

#82
20080220003
2008-09-11

C5a receptor antagonists

#83
20080194522
2008-08-14

Development of Fluorogenic Substrates For Monoamine Oxidases (Mao-A and Mao-B)

#84
20080182891
2008-07-31

CHROMANE AND CHROMENE DERIVATIVES AND USES THEREOF

#85
20080171123
2008-07-17

Technically Produced Dihydrocoumarin

#86
20070054909
2007-03-08

VLA-4 inhibitor compounds

#87
20070010691
2007-01-11

Enantioselective synthesis of enantiomerically enriched compounds

#88
20060258714
2006-11-16

Chromane and chromene derivatives and uses thereof

#89
20060251786
2006-11-09

Cyclopropanated coumarin derivatives

#90
20060178405
2006-08-10

Benzopyran compounds, process for preparing the same and their use

#91
20060131541
2006-06-22

Dihydrocoumarin derivative, liquid crystal composition containing the same, and liquid crystal display device

#92
20050288350
2005-12-29

Bicyclic androgen and progesterone receptor modulator compounds and methods

#93
20050222437
2005-10-06

Process for the preparation of tolterodine and intermediates thereof

#94
20050014818
2005-01-20

Process for producing optically active chroman derivative and intermediate